Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Shares Repurchased (2016 - 2024)

OptimizeRx (OPRX) has disclosed Shares Repurchased for 5 consecutive years, with $1.6 million as the latest value for Q4 2024.

  • Quarterly Shares Repurchased rose 510.0% to $1.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2024, up 0.65% year-over-year, with the annual reading at $6.7 million for FY2024, 14.23% down from the prior year.
  • Shares Repurchased hit $1.6 million in Q4 2024 for OptimizeRx, up from $1.6 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $12.2 million in Q3 2022 to a low of $270000.0 in Q4 2023.
  • Historically, Shares Repurchased has averaged $3.3 million across 3 years, with a median of $1.7 million in 2024.
  • Biggest five-year swings in Shares Repurchased: plummeted 96.38% in 2023 and later soared 510.0% in 2024.
  • Year by year, Shares Repurchased stood at $7.5 million in 2022, then tumbled by 96.38% to $270000.0 in 2023, then skyrocketed by 510.0% to $1.6 million in 2024.
  • Business Quant data shows Shares Repurchased for OPRX at $1.6 million in Q4 2024, $1.6 million in Q3 2024, and $1.8 million in Q2 2024.